Users of Title X family planning services are disproportionately…
Source Office of Population Affairs.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Source Office of Population Affairs.
A new Kaiser Family Foundation report released today finds how health insurance carriers are interpreting and implementing the Affordable Care Act's contraceptive coverage requirement varies, limiting contraceptive options for some women.
A new KFF (Kaiser Family Foundation) analysis finds that donor government support for global family planning efforts totaled US$1.27 billion in 2017, up 6 percent from 2016 but still below its 2014 peak. Funding from the United States, the world’s largest donor, declined from US$532.7 in 2016 to US$488.
The day after the midterm elections, the Trump Administration moved forward with anticipated regulatory changes governing employer exemption from the Affordable Care Act’s (ACA) contraceptive coverage mandate based on religious or moral objections.
The latest KFF Poll examines the public’s attitudes towards different facets of reproductive health care in light of recent policy changes made by the Trump administration. This poll examines attitudes towards major changes to the Title X program and attitudes toward state-level laws restricting abortions after a fetal heartbeat has been detected. The poll also looks at public awareness of provisions related to women’s health that are part of the 2010 Affordable Care Act.
In light of the new final rule regarding use of Title X federal funds for family planning clinics, Alina Salganicoff, Vice President and Director of Women’s Health Policy at KFF, answers three questions about their impact on women and the clinics that treat them.
Intrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews the various IUDs approved by the FDA; awareness, use, and availability of IUDs; and key issues in insurance coverage and financing of IUDs in the United States.
On April 15th, the Department of Health and Human Services (HHS) published proposed regulations for the Title X federal family planning program to replace the Trump Administration’s rules, which prohibited abortion referrals and co-located abortion services.
At 12:30 p.m. ET on Wednesday, April 21, KFF will hold a web briefing to highlight key findings on sexual and reproductive health from KFF’s national Women’s Health Survey. The presentation will be followed by a discussion with leaders in sexual and reproductive care about what those findings mean for policy and practice, how the pandemic has begun to reshape the provision of sexual and reproductive health care, and implications for the future of the family planning safety net and the people who rely on it.
This issue brief provides a summary of the major policies and statutory requirements governing U.S. participation in international family planning and reproductive health efforts. These laws and policies collectively direct how funds are spent, which organizations receive funds and generally shape U.S. family planning and reproductive health activities around the world.
© 2025 KFF